hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the cancer has spread to other areas or is in a more advanced stage.
Prognostic factors of the risk of recurrence and of hormone dependence in prostate cancer were studied in a randomised prospective study comparing 3 months neoadjuvant GnRh-analouge treatment followed by radical prostatectomy (55 patients) and surgery alone (56 patients). We found tumour growth at ...
The prognosis ofprostate canceror the probability of relapse following primary therapy depends on the clinical stage of the tumor, Gleason score (histologic grade) and the PSA level before the primary treatment. The other important independent prognostic factors include the pathologic stage of the tumo...
Lack of response come always together with a poor prognosis, and there is 90% mortality at 2 years. Advanced prostatic cancer should not be treated with hormones if the patient has few symptoms and his quality of life is satisfactory. Symptomatic forms require hormone manipulation. Orchidectomy ...
undetected/untreated prostate cancer. Conversely, men over 70 often have more indolent or slow-growing prostate cancers or other medical conditions that may be greater threats to their lives over the next 10 years than may prostate cancer, and thus less aggressive evaluation and treatment may be ...
undetected/untreated prostate cancer. Conversely, men over 70 often have more indolent or slow-growing prostate cancers or other medical conditions that may be greater threats to their lives over the next 10 years than may prostate cancer, and thus less aggressive evaluation and treatment may be ...
In conclusion, our study provided prognostic factors for prostate cancer and detected a bone metastasis pattern in patients. Younger age, married marital status and Asian race were better prognosis factors in social charecteristics. Lower PSA level, lower Gleason scores, positive treatment and no ...
CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer....
For patients with metastatic hormone-sensitive prostate cancer, what are the treatment options? Alicia Morgans, M.D., MPH: Metastatic hormone-sensitive prostate cancer is a particular type or stage of prostate cancer in which the cancer has spread outside of the prostate—that's the metastatic ...
There is no high level clinical evidence for treatment selection among these choices based on biological drivers of clinical disease. In August 2020, the Prostate Cancer Foundation convened a working group to meet and discuss biomarkers for hormone-sensitive prostate cancer, the proceedings of which ...